CN110101089A - A kind of diet fiber composition with hypoglycemic and effect of weight reducing - Google Patents
A kind of diet fiber composition with hypoglycemic and effect of weight reducing Download PDFInfo
- Publication number
- CN110101089A CN110101089A CN201910312423.XA CN201910312423A CN110101089A CN 110101089 A CN110101089 A CN 110101089A CN 201910312423 A CN201910312423 A CN 201910312423A CN 110101089 A CN110101089 A CN 110101089A
- Authority
- CN
- China
- Prior art keywords
- composition
- weight
- mouse
- diet
- fiber composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 89
- 235000005911 diet Nutrition 0.000 title claims abstract description 50
- 230000037213 diet Effects 0.000 title claims abstract description 50
- 239000000835 fiber Substances 0.000 title claims abstract description 40
- 230000000694 effects Effects 0.000 title claims abstract description 15
- 230000002218 hypoglycaemic effect Effects 0.000 title claims abstract description 6
- 230000001603 reducing effect Effects 0.000 title claims description 5
- 235000013312 flour Nutrition 0.000 claims abstract description 19
- 235000007340 Hordeum vulgare Nutrition 0.000 claims abstract description 13
- 229920002752 Konjac Polymers 0.000 claims abstract description 13
- 229920001202 Inulin Polymers 0.000 claims abstract description 12
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 12
- 229940029339 inulin Drugs 0.000 claims abstract description 12
- 239000000843 powder Substances 0.000 claims abstract description 11
- 241000209219 Hordeum Species 0.000 claims description 13
- 238000002474 experimental method Methods 0.000 abstract description 12
- 241001465754 Metazoa Species 0.000 abstract description 4
- 238000012360 testing method Methods 0.000 abstract description 3
- 240000005979 Hordeum vulgare Species 0.000 abstract 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 44
- 235000013325 dietary fiber Nutrition 0.000 description 44
- 210000004185 liver Anatomy 0.000 description 29
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 20
- 239000008103 glucose Substances 0.000 description 15
- 241000699670 Mus sp. Species 0.000 description 13
- 210000004369 blood Anatomy 0.000 description 13
- 239000008280 blood Substances 0.000 description 13
- 239000003925 fat Substances 0.000 description 13
- 230000007423 decrease Effects 0.000 description 12
- 235000013305 food Nutrition 0.000 description 11
- 230000009182 swimming Effects 0.000 description 11
- 235000012000 cholesterol Nutrition 0.000 description 9
- 150000002632 lipids Chemical class 0.000 description 9
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 208000031226 Hyperlipidaemia Diseases 0.000 description 6
- 206010020772 Hypertension Diseases 0.000 description 6
- 108010023302 HDL Cholesterol Proteins 0.000 description 5
- 230000009102 absorption Effects 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 5
- 235000019007 dietary guidelines Nutrition 0.000 description 5
- 201000001421 hyperglycemia Diseases 0.000 description 5
- 230000000968 intestinal effect Effects 0.000 description 5
- 235000015097 nutrients Nutrition 0.000 description 5
- 150000003626 triacylglycerols Chemical class 0.000 description 5
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 4
- 208000004930 Fatty Liver Diseases 0.000 description 4
- 206010019708 Hepatic steatosis Diseases 0.000 description 4
- 108010028554 LDL Cholesterol Proteins 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 150000001720 carbohydrates Chemical class 0.000 description 4
- 235000014633 carbohydrates Nutrition 0.000 description 4
- 208000010706 fatty liver disease Diseases 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 235000013402 health food Nutrition 0.000 description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 description 4
- 239000011707 mineral Substances 0.000 description 4
- 235000010755 mineral Nutrition 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 230000036186 satiety Effects 0.000 description 4
- 235000019627 satiety Nutrition 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 231100000240 steatosis hepatitis Toxicity 0.000 description 4
- 230000004584 weight gain Effects 0.000 description 4
- 235000019786 weight gain Nutrition 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 229920002498 Beta-glucan Polymers 0.000 description 3
- 208000008589 Obesity Diseases 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 208000030159 metabolic disease Diseases 0.000 description 3
- 235000020824 obesity Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- 206010022489 Insulin Resistance Diseases 0.000 description 2
- 238000012449 Kunming mouse Methods 0.000 description 2
- 201000002451 Overnutrition Diseases 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 208000016097 disease of metabolism Diseases 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000008821 health effect Effects 0.000 description 2
- 235000004280 healthy diet Nutrition 0.000 description 2
- 235000009200 high fat diet Nutrition 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 230000000116 mitigating effect Effects 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 235000020823 overnutrition Nutrition 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 2
- 230000004580 weight loss Effects 0.000 description 2
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 244000298479 Cichorium intybus Species 0.000 description 1
- 235000007542 Cichorium intybus Nutrition 0.000 description 1
- 244000205754 Colocasia esculenta Species 0.000 description 1
- 235000006481 Colocasia esculenta Nutrition 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 229920002581 Glucomannan Polymers 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 102000015779 HDL Lipoproteins Human genes 0.000 description 1
- 240000008892 Helianthus tuberosus Species 0.000 description 1
- 235000003230 Helianthus tuberosus Nutrition 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 241000581650 Ivesia Species 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 101000800132 Mus musculus Thyroglobulin Proteins 0.000 description 1
- 241001529246 Platymiscium Species 0.000 description 1
- 235000012377 Salvia columbariae var. columbariae Nutrition 0.000 description 1
- 240000005481 Salvia hispanica Species 0.000 description 1
- 235000001498 Salvia hispanica Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 241001532014 Xanthorrhoea Species 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019577 caloric intake Nutrition 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 235000014167 chia Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000035614 depigmentation Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000013118 diabetic mouse model Methods 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 235000005523 excessive nutrition Nutrition 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000012048 forced swim test Methods 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229940046240 glucomannan Drugs 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000003516 hyperlipidaemic effect Effects 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 231100000272 reduced body weight Toxicity 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000013585 weight reducing agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A23L33/22—Comminuted fibrous parts of plants, e.g. bagasse or pulp
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/733—Fructosans, e.g. inulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The invention discloses a kind of diet fiber composition, it is by following weight proportion at being grouped as: highland barley flour 30-83%, inulin 10-30%, konjaku flour 5-20%, odd Asia seed powder 2-20%.Animal test results show that the diet fiber composition has effects that weight-reducing and hypoglycemic, will not cause again after edible the excess weight of mouse reduce with it is faint.Human experiment the experimental results showed that, the present invention can be substantially reduced the BMI index of obese people, and after cutting out after half a year, and BMI index does not have a rebound phenomenon, therefore have preferable health-care effect.
Description
Technical field
The invention belongs to field of health care food, and in particular to a kind of dietary fiber group with hypoglycemic and effect of weight reducing
Close object.
Background technique
With the continuous improvement of Living consumption, metabolic disease such as hypertension, hyperglycemia (diabetes), hyperlipemia
The disease incidence such as disease, high lithemia are higher and higher.Metabolic disease is mostly related with overnutrition, scientific investigations showed that, overnutrition draws
The obesity and " four is high " symptom of hair are directly related.Therefore, excessive Nutrients Absorption is controlled or reduces gradually to be regarded as by people
A kind of important health care mode.Low in calories, high satiety is a kind of diet mould for controlling excessive Nutrition intake for food and drink food
Formula, wherein dietary fiber is due to that can provide high satiety while have both low in calories, moreover it is possible to beneficial work is played to beneficial bacteria of intestinal tract
With the " the 7th be also therefore defined as by academia after protein, carbohydrate, fat, water, vitamin and mineral
Kind nutrient ".Dietary fiber is the important component of various generation food and drink foods or health food on the market at present.
However, excessive intake dietary fiber might not be advantageous to human body, " Chinese residents dietary guidelines 2016 editions " is built
View, the daily ingestion of dietary fiber of adult are advisable with 30g or so.Excessive intake dietary fiber, not only results in body pair
The Replacement effect of absorption of nutrient ingredients reduces the control weight effect eaten for food and drink；Can also hinder body absorb carbohydrate,
The microelements such as protein, fat and minerals, vitamin cause the shortage symptom of nutrient.Therefore, ensuring diet fibre
On the basis of total intake of dimension, scientifically collocation is very crucial using dietary fiber.Have on the market largely about diet at present
The report of fiber composition, but most of function of only focusing on Weight-reducing and lipid-lowering, and people should be matched by having ignored dietary fiber itself
The absorbing structure of body nutrient, so as to cause following defect: (1) dosage of dietary fiber and collocation are unreasonable, stop after eating,
Because the compensation of body is easy to the rebound for the physical signs such as weight body fat occur；(2) after long term consumer is edible due to
The intake of the microelements such as carbohydrate, protein, fat and minerals, vitamin is affected, it may appear that physical strength, resistance
Power decline, or even cause the diseases such as malnutrition.
Summary of the invention
The purpose of the present invention is aiming at the problem that most of dietary fibers on the market do not match human nutrition element absorbing structure,
On the basis of receiving traditional medicine compatibility idea, in conjunction with the Advanced Idea of modern nutriology, experienced by zoopery and people
The method of card provides a kind of more reasonable diet fiber composition type and its proportion of arranging in pairs or groups.The diet fiber composition is not
It is only capable of providing satiety, while promoting the growth of intestine beneficial bacteria colony, and have and lose weight, alleviate hyperglycemia, hyperlipidemia, rouge
The effect of fat liver and hypertension, high lithemia.Importantly, this diet fiber composition is eaten for a long time, weak nothing will not be caused
Power；After stopping eats this diet fiber composition, the Diet lifestyle of health is maintained, indices in a long time will not
Rebound.
Diet fiber composition provided by the invention is by following weight proportion at being grouped as: highland barley flour 50-83%, chrysanthemum
Powder 10-30%, konjaku flour 5-20%, odd Asia seed powder 2-20%.
Preferably, the weight proportion of the ingredient is: highland barley flour 70%, inulin 13%, konjaku flour 9%, odd Asia seed powder
8%.
Highland barley is also known as naked barley, is a kind of cereal of grass tree section Hordeum, is more common in the plateaus such as China Qinghai, Tibet
Band.Non-starch polysaccharide beta glucan rich in highland barley, current study show that, β-glucan is that one kind can be by human body
The dietary fiber being absorbed and utilized has cleaning enteron aisle, adjusts blood glucose, reduces cholesterol and improve the big function of immunity four.
Inulin is the deposit polysaccharide in a kind of plant, typically from jerusalem artichoke, witloof stem tuber in.Inulin is a kind of excellent
The soluble dietary fiber of matter, and can effectively be utilized by intestinal flora.Currently, inulin has become a kind of important bifid bar
Bacterium proliferation factor.
Konjaku flour is in Araeceae konjaku platymiscium, konjaku glucomannan ingredient rich in, in water
Sticky jelly can be formed, promotes the wriggling of enteron aisle and satiety is provided, meanwhile, konjaku flour can also provide battalion for intestinal flora
It supports, promote the generation of probiotics and synthesizes the substance beneficial to human body.
Odd Asia seed is a kind of food of South America state Mexico area specialty, also known as chia kind.Since it is abundant
Nutritive value and good mouthfeel, have become the new resource food in China.Odd Asia seed is rich in dietary fiber, eats after immersion
Control caloric intake, the effect of relax bowel and defecation can be played.
Dietary fiber is generally classified according to dissolubility, and soluble dietary fiber and insoluble dietary fiber two are divided into
Major class, most diet fiber compositions are to carry out formula design according to this classification method on the market at present, however, this
It can not be accurately reflected in the feature of people's body absorption metabolism according to the classification method that the physical property of dietary fiber carries out.
Dietary fiber is divided into three categories according to dietary fiber in the intracorporal digestion and absorption situation of people by the present invention again: (1) can be by people
The dietary fiber that body is absorbed and utilized, the dietary fiber that (2) can be utilized by intestinal flora fermentation, (3) completely anti-digestibility and utilization
Dietary fiber.
In order to more preferably match the characteristics of human nutrition element absorbs, in diet fiber composition provided by the invention, highland barley institute
The beta glucan class dietary fiber of offer is the dietary fiber that can be utilized by human body slow-absorbing, and inulin and konjaku flour are can
The dietary fiber utilized by intestinal flora fermentation, the dietary fiber that odd Asia seed provides are the dietary fiber of completely anti-digestibility and utilization,
The weight ratio of three classes dietary fiber is 50-83:15-50:2-20.
Animal test results show: (1) diet fiber composition provided by the invention can reduce the weight of obesity mice, long
The phase edible excess weight that will not cause mouse again reduces and faint.(2) diet fiber composition can also reduce mouse
Fasting blood-glucose, TG, TC, the LDL-C reduced in serum is horizontal, and it is horizontal to increase HDL-C, reduces liver coefficient and the total gallbladder of liver is solid
Alcohol content illustrates that the present invention also has the function of hypoglycemic and improves fatty liver.
Human experiment is the results showed that the present invention can be substantially reduced the BMI index of obese people, and cut out
After half a year, BMI value does not have a rebound phenomenon, therefore has better health-care effect.BMI (personal body mass index) is mesh
The preceding fat or thin degree of common measurement human body in the world and whether Jian Kang a standard.Studies have shown that fat and insulin supports
Resist it is closely related, insulin resistance be cause 2 patients with type Ⅰ DM one of key factor, insulin resistance simultaneously and hyperlipidemia, height
The metabolic diseases such as uric acid, hypertension have close association.
It is significantly, because current is most that the BMI index of obese people, which reduces in weight-reducing class health food,
Added dietary fiber can not only make subject different degrees of physical strength occur, resist after long-term consumption in number diet products
Power decline, while being also easy to rebound after stopping eating, BMI index is even likely to be more than using before diet products.This
Diet fiber composition can be continual and steady mitigation and maintain body weight, to the hyperglycemia of human body, hyperlipidemia, fatty liver,
The decline of the indexs such as hypertension and high lithemia can also have a significant effect.
Specific embodiment
The present invention is described in detail below by embodiment.
Embodiment 1
Highland barley flour, inulin, konjaku flour and Qi Ya seed powder are divided into three classes dietary fiber: the beta glucan being rich in highland barley flour
It is that one kind can be by the dietary fiber (hereinafter referred to as 1 class dietary fiber) of human body slow-absorbing, inulin and konjaku flour are a kind of energy
Enough dietary fibers (hereinafter referred to as 2 class dietary fibers) utilized by intestinal flora fermentation, the dietary fiber that odd Asia seed provides is energy
The dietary fiber (hereinafter referred to as 3 class dietary fibers) of enough completely anti-digestibility and utilizations.According to this mode classification, eight groups of differences are designed
The diet fiber composition of proportion is shown in Table in detail described in 1.
The tested diet fiber composition of table 1 matches (g)
Each crushing material is crossed into 60-100 mesh；Ultraviolet sterilization is carried out after mixing.According to " health food is examined and evaluation skill
Art specification 2003 editions ", designing animal swimming with a load attached to the body experiment, verify after edible 1 month diet fiber composition to the weight of animals and
The influence of swimming time.
120 males, 6 week old kunming mice is selected, is classified as 10 groups, every group 12.Experimental group uses MD12033 first
High glucose and high fat feed (offer of Jiangsu Mei Disen biological medicine Co., Ltd) is fed 3 months, and the weight gain of each group mouse weight is measured
Situation.Mouse of 105 weight more than Normal group weight 20% is wherein picked out altogether as model group mouse.Feed 3
After month, Normal group 10.4 ± 0.3g of weight gain, model group 20.1 ± 0.4g of weight gain, model group weight gain is Normal group
193%, have statistical significance (P < 0.05), according to the requirement in " health food examine with assessment technique specification 2003 editions ",
Illustrate this obese model modeling success.
After modeling success, the diet fiber composition described in table 1, continuous gavage are raised 1 month respectively daily, stomach-filling
(according to " Chinese residents dietary guidelines 2016 editions ", diet that adult daily intakes is fine for the human normal amount recommended for amount
Dimension amount be 30g/d, adult human body weight by 60Kg calculate) convert 1 multiple dose (being equal to human body dosage).Normal group is used
Chow diet is fed, and model control group uses always high glucose and high fat diet.Each group of every 10 days records after beginning stomach-filling
The average weight (the results are shown in Table 2) of mouse carries out mouse forced swimming test according to classical method after stomach-filling 1 month.
Mice weights are first weighed before forced swim test, and 5% weight sheet lead of mouse tail load is placed in swimming trunk middle reaches
Swimming, the depth of water are no less than 30cm, and 25 DEG C ± 1.0 DEG C of water temperature, record mouse swimming started to dead time, i.e. mice burden swimming
Time (the results are shown in Table 3).
2 each group average mice body weight (g) of table
| 0 day | 10 days | 20 days | 30 days | |
| Composition 1 | 37.6±0.2 | 35.2±0.2 | 34.3±0.2 | 33.1±0.3 |
| Composition 2 | 37.4±0.3 | 33.3±0.4 | 30.4±0.3 | 27.2±0.2 |
| Composition 3 | 36.5±0.1 | 32.1±0.6 | 28.2±0.2 | 27.1±0.3 |
| Composition 4 | 33.7±0.2 | 30.2±0.7 | 27.5±0.1 | 26.3±0.1 |
| Composition 5 | 37.1±0.5 | 33.5±0.3 | 28.7±0.5 | 26.6±0.2 |
| Composition 6 | 35.8±0.4 | 31.7±0.4 | 26.4±0.4 | 22.9±0.5* |
| Composition 7 | 34.2±0.2 | 30.2±0.1 | 24.5±0.1 | 22.2±0.3* |
| Composition 8 | 35.1±0.6 | 27.5±0.2 | 23.2±0.3 | 20.3±0.2* |
| Model comparison | 37.8±0.2 | 38.4±0.3 | 38.8±0.2 | 39.5±0.1 |
| Normal control | 24.1±0.3 | 25.2±0.1 | 26.1±0.3 | 26.3±0.6 |
* there is statistical difference, P < 0.05 compared with normal control.Every group of n=10-11.
8 composition group mouse and model control group mouse are included in after high glucose and high fat diet 3 months (i.e. in table 2
0 day) it is that modeling is successfully small；Compared with model control group, all there is difference after 10 days in each group of stomach-filling dietary fiber
The weight loss of degree.But compared with the mouse weight of Normal group, after stomach-filling dietary fiber 30 days, composition 6,7,8
The weight ratio Normal group mouse of three groups of mouse is lower, has statistical difference (P < 0.05), illustrates excessive 2 classes and 3 classes
The excess weight that dietary fiber diet can cause mouse reduces and the data (being shown in Table 3) of mice burden swimming experiment combine
It sees, excess weight reduction is unfavorable for mouse health.Contrast model control group weight, the mouse of composition 1 after continuous gavage 30 days
Weight loss is unobvious (P > 0.05 does not have statistical difference), illustrates that very few 2 classes and 3 class dietary fibers cannot obviously drop
Low mouse weight.2,3,4,5 four groups of mouse weight reducing effects of composition are preferable, both reduced weight (with model control group ratio
Compared with, P < 0.05, there is statistical difference), but do not occur phenomenon that weight drops too low (compared with Normal group, P >
0.05, do not have statistical difference).
Influence of the different diet fiber compositions of table 3 to the mice burden swimming time
| Group | Swimming time (min) |
| Composition 1 | 5.5±0.5 |
| Composition 2 | 4.9±0.4 |
| Composition 3 | 5.4±0.5 |
| Composition 4 | 5.1±0.4 |
| Composition 5 | 5.0±0.4 |
| Composition 6 | 3.7±0.3* |
| Composition 7 | 3.5±0.2* |
| Composition 8 | 2.1±0.2* |
| Model comparison | 4.5±0.5 |
| Normal control | 5.2±0.4 |
* there is statistical difference, P < 0.05 compared with normal control.Every group of n=10-11.
It compares as can be seen from the above results with Normal group, the composition 1-5 group mice burden swimming time does not have
Significant changes (P > 0.05 does not have statistical difference), illustrate that mouse ate this five groups of dietary fibers after 30 days, do not occur
The phenomenon that weak and physically-draining.And the walking weight load of tri- groups of mouse of composition 6-8 occurs being substantially reduced (P <
0.05, there is statistical difference), illustrate that excessive 2,3 class dietary fiber accountings can not only be such that mouse weight excessively reduces, and
And it can also cause the faint of mouse.
The experimental result of consolidated statement 2 and table 3: the mouse weight decline of edible composition 1 is unobvious, composition 6,7,8
For mouse because excess weight decline has caused faint phenomenon, the mouse of composition 2,3,4,5 can either be substantially reduced body
Weight, and be not in faint phenomenon.Diet fiber composition provided by the invention: highland barley flour 70%, inulin 13%, evil spirit
Taro powder 9%, odd Asia seed powder 8% (composition 3) can either be effectively reduced the weight of obesity mice, will not draw again after one month edible
Rise mouse excess weight reduce and it is faint, have optimal Weight-reducing health effect.
Embodiment 2
Select 110 males, 6 week old kunming mice, 10 are normal control, are fed with chow diet, and 100 with high in fat
High sugar feed is fed.It is injected intraperitoneally after 7d 2% streptozotocin (STZ), 0.1g/kg weight, restores diet after injecting 1h, build
Vertical diabetes B model (the method is common diabetic mouse model).The fasting blood-glucose after fasting 5h is measured after modeling,
It takes mouse of the fasting blood sugar higher than 16.7mol/L to be tested, shares 90 mouse and meet the requirements, select modeling successful
90 mouse add 10 Normal group mouse, are grouped as follows:
Diet fiber composition nursing group: totally 8 groups of diet fiber composition in table 1, every kind composition 10, totally 80；
Model control group: modeling successful subsequent continues feeding high lipid food, and 10；
Normal group: feeding chow diet always, 10.
During experiment, drinking-water is freely eaten in mouse.
1. fasting plasma glucose
It after every group of mouse is deprived of food but not water 12h, cuts caudal vein and takes blood, measure fasting blood-glucose, every 10d measurement with blood glucose meter
Once, 30d is observed altogether, the results are shown in Table 4.
4 experiment mice of table is averaged fasting blood-glucose (mmol/L)
The fasting blood sugar of model control group is all larger than equal to 11.1mmol/L, illustrates Glycemia Decline success.And model
Control is compared, and the mouse fasting blood-glucose for taking diet fiber composition decreased significantly.Wherein composition 2,3,4,5 after 30d
Group mouse fasting blood-glucose decline situation is preferable.
2. serum lipid assay
It feeds mouse until the last day, mouse is deprived of food but not water 12h posterior orbit and takes blood, is then centrifuged for isolated supernatant
Liquid, every group of sample measure total triglycerides (TG), total cholesterol (TC), low-density lipoprotein (LDL- according to kit method
C), the content (HDL-C) of high-density lipoprotein.
5 experiment mice items serum lipids index (mmol/L) of table
| TG | TC | LDL-C | HDL-C | |
| Composition 1 | 2.26 | 3.43 | 0.64 | 2.32 |
| Composition 2 | 2.13 | 3.06 | 0.51 | 2.89 |
| Composition 3 | 1.95 | 3.05 | 0.54 | 2.91 |
| Composition 4 | 2.02 | 3.05 | 0.53 | 2.92 |
| Composition 5 | 2.03 | 3.04 | 0.56 | 2.82 |
| Composition 6 | 2.21 | 3.24 | 0.64 | 2.42 |
| Composition 7 | 2.12 | 3.33 | 0.62 | 2.41 |
| Composition 8 | 2.15 | 3.11 | 0.55 | 2.78 |
| Model comparison | 2.62 | 3.51 | 0.68 | 2.29 |
| Normal control | 1.83 | 3.01 | 0.55 | 2.94 |
It is compared with Normal group, TG, TC, LDL-C of model control group are improved, and HDL-C decreases.And mould
Type control is compared, and mouse TG, TC, the LDL-C for taking diet fiber composition have different degrees of reduction, and HDL-C is mentioned
Height illustrates that diet fiber composition has the blood lipids index of diabetic mice different degrees of improvement.
5. liver coefficient and liver total cholesterol measure
After experiment, the liver of simultaneously separating mouse is dissected, is dried after being cleaned with physiological saline with filter paper, weighing calculates liver
Dirty coefficient (liver coefficient=liver weight/mouse total weight).Each group of liver takes supernatant to carry out liver after homogenized
Dirty total cholesterol level measurement.Liver coefficient reflects the content of liver fat indirectly；Total cholesterol of liver reflects in liver
The formation of blood lipid health status and hyperlipidemia, atherosclerosis have relationship.
6 experiment mice of table is averaged liver coefficient and total cholesterol of liver
| Liver coefficient (%) | Total cholesterol of liver (mmol/L) | |
| Composition 1 | 3.92 | 0.22 |
| Composition 2 | 3.62 | 0.17 |
| Composition 3 | 3.59 | 0.15 |
| Composition 4 | 3.54 | 0.12 |
| Composition 5 | 3.65 | 0.14 |
| Composition 6 | 3.77 | 0.16 |
| Composition 7 | 3.72 | 0.15 |
| Composition 8 | 3.76 | 0.21 |
| Model comparison | 4.43 | 0.25 |
| Normal control | 3.53 | 0.09 |
It is compared with Normal group, the average liver coefficient of model control group is higher with total cholesterol of liver, illustrates mould
Type control group mice hepatic fat content is higher；It is compared with model comparison, the mouse for taking diet fiber composition is averaged liver
Coefficient and total cholesterol of liver have different degrees of reduction, illustrate that liver fat amount decreases, hyperlipidaemic conditions are changed
It is kind.
Consolidated statement 4, table 5, the content of table 6, composition 1 is to the fasting blood-glucose of mouse, serum lipids, liver coefficient and liver
Total cholesterol improves less obvious；Although composition 6,7,8 also can blood lipid to mouse, liver index have improvement, tie
Embodiment 1 is closed, the mouse of composition 6,7,8 is because excess weight decline has caused faint phenomenon.Composition 2,3,4,5
Mouse both improved blood glucose, blood lipid and liver index, and be again not in faint while being substantially reduced weight
The phenomenon that.In conclusion diet fiber composition provided by the invention can either improve blood glucose, blood lipid and liver index, it is long
Phase is edible and mouse will not be made faint situation occur while weight significantly reduces, and has better Weight-reducing health effect
Fruit.
Embodiment 3
The present embodiment investigates diet fiber composition of the present invention to personal body mass index (BMI) by human experiment experiment
Influence, and then reflect diet fiber composition to the hyperlipidemia of volunteer, hyperglycemia, hypertension, high lithemia and fatty liver
Etc. indexs decline whether have the effect of it is certain.
It is fat (BMI > 28) 40 (each 20 of men and women) to choose weight, age bracket is 30-55 years old, the every Tiangeng of these volunteers
According to itself age, height, weight, daily activity, set according to the heat Calculation formula in " Chinese residents dietary guidelines 2016 "
Count recommending recipes, thermal range 2100-2700kcal/d.It is designed in recipe and takes a packet (20g) dietary fiber composition every night
Object (composition 3 in table 1: highland barley flour 70%, inulin 13%, konjaku flour 9%, odd Asia seed powder 8%), and deducted in master menu
The corresponding heat of diet fiber composition.It is taken after diet fiber composition is stirred evenly with 200-300mL warm water.Continuously take half
Year, the every two moon records volunteer's weight, and monthly follow-up records subjectivity sense of the volunteer to own bodies situation
By.After cutting out diet fiber composition, continue follow-up volunteer half a year, volunteer keeps above-mentioned " Chinese residents during this
Dietary guidelines 2016 " in recommend healthy diet, weight of two months records, observe BMI whether have rebound.Because it is personal because
Element, this observation midway are total to depigmentation volunteer 4 (male 1, women 3), final observation number 36.
Influence of 7 diet fiber composition of table to BMI
The above human experiment the experimental results showed that, persistently take diet fiber composition within 6 months, aspiration can be obviously improved
The BMI of the weight of person, volunteer is reduced to from fat level close to normal level.Cutting out diet fiber composition
Weight is observed in half a year, in the case where volunteer keeps the healthy diet recommended in " Chinese residents dietary guidelines 2016 ", will
The phenomenon that BMI value of hope person is not changed significantly, is not had a rebound.Since this diet fiber composition can be continual and steady
Mitigation and maintain volunteer BMI, to indexs such as the hyperlipidemia of volunteer, hyperglycemia, hypertension, high lithemia and fatty livers
Decline should also have certain effect.Meanwhile being recognized by follow-up and keeping good spirit in volunteer 12 months
There is not the digestion and absorptions problem such as abdominal pain, flatulence, constipation in situation, also without occur in default of carbohydrate, fat,
The faint equal malnutritive problem of protein and dimension minerals initiation.
Claims (2)
1. a kind of diet fiber composition with hypoglycemic and effect of weight reducing, it is characterised in that by following weight proportion at
It is grouped as: highland barley flour 50-83%, inulin 10-30%, konjaku flour 5-20%, odd Asia seed powder 2-20%.
2. diet fiber composition as described in claim 1, it is characterised in that by following weight proportion at being grouped as: highland barley
Powder 70%, inulin 13%, konjaku flour 9%, odd Asia seed powder 8%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910312423.XA CN110101089A (en) | 2019-04-18 | 2019-04-18 | A kind of diet fiber composition with hypoglycemic and effect of weight reducing |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910312423.XA CN110101089A (en) | 2019-04-18 | 2019-04-18 | A kind of diet fiber composition with hypoglycemic and effect of weight reducing |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110101089A true CN110101089A (en) | 2019-08-09 |
Family
ID=67485689
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910312423.XA Pending CN110101089A (en) | 2019-04-18 | 2019-04-18 | A kind of diet fiber composition with hypoglycemic and effect of weight reducing |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110101089A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110801026A (en) * | 2019-10-25 | 2020-02-18 | 运鸿集团股份有限公司 | Dietary fiber compound nutrient with weight-losing and lipid-lowering effects and preparation method thereof |
| CN110810694A (en) * | 2019-11-14 | 2020-02-21 | 王艳辉 | Special blood sugar reducing solid beverage for diabetic patients and preparation and use methods thereof |
| CN112806512A (en) * | 2020-08-21 | 2021-05-18 | 湖南汇富康达健康管理研究院(有限合伙) | Dietary fiber solid beverage capable of relaxing bowels and preparation method thereof |
| CN115624565A (en) * | 2022-11-10 | 2023-01-20 | 上海交通大学 | Highland barley tender leaf water-extraction polysaccharide with weight-losing and lipid-lowering effects and application thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106901367A (en) * | 2017-03-14 | 2017-06-30 | 张勇 | The composition and preparation method and purposes of a kind of balance blood sugar |
| CN108260811A (en) * | 2016-12-30 | 2018-07-10 | 西藏天麦力健康品有限公司 | It is a kind of that there is the health food and its processing method lost weight and improve function of intestinal canal |
-
2019
- 2019-04-18 CN CN201910312423.XA patent/CN110101089A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108260811A (en) * | 2016-12-30 | 2018-07-10 | 西藏天麦力健康品有限公司 | It is a kind of that there is the health food and its processing method lost weight and improve function of intestinal canal |
| CN106901367A (en) * | 2017-03-14 | 2017-06-30 | 张勇 | The composition and preparation method and purposes of a kind of balance blood sugar |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110801026A (en) * | 2019-10-25 | 2020-02-18 | 运鸿集团股份有限公司 | Dietary fiber compound nutrient with weight-losing and lipid-lowering effects and preparation method thereof |
| CN110810694A (en) * | 2019-11-14 | 2020-02-21 | 王艳辉 | Special blood sugar reducing solid beverage for diabetic patients and preparation and use methods thereof |
| CN112806512A (en) * | 2020-08-21 | 2021-05-18 | 湖南汇富康达健康管理研究院(有限合伙) | Dietary fiber solid beverage capable of relaxing bowels and preparation method thereof |
| CN115624565A (en) * | 2022-11-10 | 2023-01-20 | 上海交通大学 | Highland barley tender leaf water-extraction polysaccharide with weight-losing and lipid-lowering effects and application thereof |
| CN115624565B (en) * | 2022-11-10 | 2024-03-26 | 上海交通大学 | Highland barley tender leaf water-extracted polysaccharide with weight-losing and lipid-lowering effects and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110101089A (en) | A kind of diet fiber composition with hypoglycemic and effect of weight reducing | |
| CN102187887B (en) | Sandwich biscuit with functions of losing weight and regulating blood sugar and production method thereof | |
| CN105795468A (en) | Composition having efficacy of losing weight | |
| CN102406860A (en) | Composition for preventing and treating diabetes, and preparation method and use thereof | |
| CN109511851A (en) | A kind of solid beverage and preparation method thereof before the meal reducing food glycemic index | |
| CN107518418A (en) | Application of the dietary fiber as metabolism regulators | |
| CN104431741A (en) | Cereal conditioning porridge and making method and application thereof | |
| CN1980682A (en) | Flaxseeds for body weight management | |
| CN107836640A (en) | A kind of high-fiber high-protein alimentary paste and preparation method thereof | |
| CN107006761A (en) | It is a kind of suitable for nutritional meal replacement powder of patients with diabetes mellitus and preparation method thereof | |
| CN104621566A (en) | Lactobacillus-fermented barley extract as well as preparation method and application thereof | |
| CN102204649B (en) | Healthcare food for regulating and stabilizing blood sugar and method for preparing same | |
| CN110292175A (en) | Have effects that composition that hypoglycemic and fat reducing is shaped and its production method and application | |
| CN100444746C (en) | A refined health food of high and cold mountain area crop and processing technology thereof | |
| CN111213690A (en) | Formula and preparation method of low-GI chickpea starch bread | |
| CN114651982A (en) | Composition capable of delaying postprandial blood sugar, preparation method and application thereof | |
| CN103535708B (en) | Technology for reducing in-vivo decomposition and absorption speeds of starch | |
| CN103535576B (en) | Meal replacement powder containing pollen | |
| CN112262956A (en) | Slowly digestible low glycemic index food and preparation method thereof | |
| CN109965290B (en) | Meal replacement powder for improving intestinal flora and application thereof | |
| CN110179037A (en) | A kind of composite dietary generation meal solid beverage and preparation method thereof | |
| CN102919959A (en) | Beverage taking lotus leaves and wheat bran as main material and production method of same | |
| CN108450941A (en) | A kind of dietary composition adjusting lipid metaboli | |
| CN105918415A (en) | Crude fiber-containing functional health biscuits and preparation method thereof | |
| CN104336511A (en) | Balanced-nutrition coarse food particles and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190809 |